Clinical trial
A Phase 3 Clinical Trial to Assess Perfusion and Obstruction Identified by Non-Invasive Technology Using PB127 Ultrasound Contrast Agent in Patients With Suspected Obstructive Coronary Artery Disease II
NCT00584896 is registered in ClinicalTrials.gov with Point Biomedical as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Phase 3 Clinical Trial to Assess Perfusion and Obstruction Identified by Non-Invasive Technology Using PB127 Ultrasound Contrast Agent in Patients With Suspected Obstructive Coronary Artery Disease II
- Lead sponsor
- Point Biomedical
- Phase
- Phase 3
- Overall status
- Terminated
- Start date
- October 31, 2007
- Completion date
- July 31, 2008
- Enrollment
- 1,000 (estimated)
- Sites
- 40
Conditions
As the registry lists them; a condition with its own page is linked.